piperacillin has been researched along with Pain in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (36.84) | 18.2507 |
| 2000's | 8 (42.11) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Effraim, P; Li, L; Tham, SW; Waxman, S | 1 |
| Bhanot, N; Makadia, J; Min, Z; Rapsinski, GJ | 1 |
| Backonja, MM; Duan, RW; Nothaft, W; Rowbotham, MC; Thomas, J | 1 |
| Sindrup, SH | 1 |
| Dyhr, H; Grunnet, M; Munro, G | 1 |
| Baker, S; Brown, J; Chandran, P; Chin, CL; Decker, MW; Fox, GB; Gauvin, D; Gomez, E; Gopalakrishnan, M; Honore, P; Jacobson, PB; Komater, V; Lee, CH; Lewis, LG; Mikusa, J; Pai, M; Rustay, NR; Salyers, A; Simler, G; Tovcimak, A; Zhong, C; Zhu, CZ | 1 |
| Decker, MW; Honore, P; Lynch, JJ; Mikusa, JP; Wade, CL | 1 |
| Baraznenok, IL; Claesson, A; Jonsson, E | 1 |
| Chin, CL; Fox, GB; Hradil, V; Luo, Y; McGaraughty, S; Skoubis, PD | 1 |
| Honore, P; Joshi, SK; Mikusa, JP; Weaver, B | 1 |
| Arneric, SP; Bannon, AW; Bitner, RS; Curzon, P; Decker, MW; Diaz, A; Dickenson, AH; Donnelly-Roberts, D; Holladay, MW; Porsolt, RD; Puttfarcken, PS; Williams, M | 1 |
| Anderson, DJ; Arneric, SP; Bannon, AW; Briggs, CA; Buckley, MJ; Campbell, JE; Decker, MW; Donnelly-Roberts, DL; He, Y; Holladay, MW; Kim, DJ; Kuntzweiler, TA; Lin, NH; Piattoni-Kaplan, M; Ryther, KB; Wasicak, JT; Williams, M | 1 |
| Arneric, SP; Bannon, AW; Buckley, MJ; Decker, MW; Holladay, MW; Kim, DJ; Lin, NH; Ryther, KB; Wasicak, JT; Williams, M | 1 |
| Arneric, SP; Bannon, AW; Bitner, RS; Curzon, P; Decker, MW; Nikkel, AL | 1 |
| Arneric, SP; Bannon, AW; Campbell, JE; Decker, MW; Kim, DJ | 1 |
| Carstens, E; Jinks, SL | 1 |
| Anderson, DJ; Dart, MJ; Decker, MW; Kim, KH; Meyer, MD; Rueter, LE; Sullivan, JP; Williams, M | 1 |
| Bowes, MA; Cube, R; Gentry, CT; Kesingland, AC; Panesar, MS; Urban, L; Vernier, JM; Walker, K | 1 |
1 trial(s) available for piperacillin and Pain
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain.
Topics: Aged; Analgesics, Non-Narcotic; Azetidines; Data Interpretation, Statistical; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Pain; Pain Measurement; Pyridines; Socioeconomic Factors; Treatment Outcome | 2009 |
18 other study(ies) available for piperacillin and Pain
| Article | Year |
|---|---|
Between fire and ice: refractory hypothermia and warmth-induced pain in inherited erythromelalgia.
Topics: Anti-Bacterial Agents; Child; Cold Temperature; Erythromelalgia; Female; Furosemide; Hot Temperature; Humans; Hypothermia; Mutation, Missense; NAV1.7 Voltage-Gated Sodium Channel; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polyethylene Glycols; Rewarming; Skin Diseases, Vesiculobullous; Sodium Potassium Chloride Symporter Inhibitors; Surface-Active Agents; Thyroxine; Treatment Outcome; Vancomycin | 2017 |
Pseudomonas mendocina native valve infective endocarditis: a case report.
Topics: Anti-Bacterial Agents; Bandages; Debridement; Endocarditis, Bacterial; Heart Valve Diseases; Humans; Leg Ulcer; Male; Middle Aged; Pain; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas Infections; Pseudomonas mendocina; Treatment Outcome | 2016 |
Nicotinic acetylcholine receptor agonism: progress in the management of neuropathic pain?
Topics: Azetidines; Excitatory Amino Acid Antagonists; Humans; Lamotrigine; Nicotinic Agonists; Pain; Peripheral Nervous System Diseases; Pyridines; Receptors, Nicotinic; Triazines | 2009 |
Selective potentiation of gabapentin-mediated antinociception in the rat formalin test by the nicotinic acetylcholine receptor agonist ABT-594.
Topics: Amines; Analgesics; Animals; Azetidines; Cyclohexanecarboxylic Acids; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Duloxetine Hydrochloride; Exploratory Behavior; Gabapentin; gamma-Aminobutyric Acid; Male; Mecamylamine; Morphine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pyridines; Rats; Rats, Sprague-Dawley; Thiophenes | 2010 |
Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
Topics: Allosteric Regulation; Analgesics; Animals; Azetidines; Behavior, Animal; Body Temperature; Brain; Disease Models, Animal; Drug Therapy, Combination; Magnetic Resonance Imaging; Male; Nicotinic Agonists; Osteoarthritis; Oxadiazoles; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic | 2011 |
ABT-594 (a nicotinic acetylcholine agonist): anti-allodynia in a rat chemotherapy-induced pain model.
Topics: Acetylcholine; Analgesia; Animals; Azetidines; Chlorisondamine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Mecamylamine; Naloxone; Nicotinic Agonists; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Time Factors; Vincristine | 2005 |
3-(2,5-Dihydro-1H-pyrrol-2-ylmethoxy)pyridines: synthesis and analgesic activity.
Topics: Analgesics, Non-Narcotic; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Mice; Models, Chemical; Molecular Structure; Pain; Pyridines | 2005 |
Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
Topics: Acetylcholine; Anesthetics, Intravenous; Animals; Azetidines; Brain; Brain Mapping; Cerebrovascular Circulation; Chloralose; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Magnetic Resonance Imaging; Male; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission; Up-Regulation; Wakefulness | 2006 |
Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain.
Topics: Analgesics; Animals; Azetidines; Behavior, Animal; Brain; Chlorisondamine; Cyclophosphamide; Cystitis; Disease Models, Animal; Male; Mecamylamine; Morphine; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain; Pyridines; Quaternary Ammonium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Viscera | 2008 |
Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors.
Topics: Analgesics, Non-Narcotic; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Capsaicin; Dose-Response Relationship, Drug; In Vitro Techniques; Ligands; Mecamylamine; Morphine; Nerve Fibers; Neuromuscular Junction; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pain Measurement; Pyridines; Rats; Receptors, Nicotinic; Spinal Cord; Substance Withdrawal Syndrome; Synaptic Transmission | 1998 |
Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptors.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Diastole; Female; Humans; Injections, Intraperitoneal; Kinetics; Mice; Molecular Structure; Muscle Contraction; Neuroblastoma; Neurons; Nicotinic Agonists; Oocytes; Pain; Pain Measurement; Pyridines; Rats; Receptors, Nicotinic; Recombinant Proteins; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Xenopus | 1998 |
Does frog toxin represent a giant leap for treatment of pain?
Topics: Analgesics, Non-Narcotic; Animals; Azetidines; Humans; Pain; Pyridines | 1998 |
Antinociceptive effects of the novel neuronal nicotinic acetylcholine receptor agonist, ABT-594, in mice.
Topics: Analgesics, Non-Narcotic; Animals; Azetidines; Hexamethonium; Lethal Dose 50; Male; Maze Learning; Mecamylamine; Mice; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Neurons; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pyridines | 1998 |
Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons.
Topics: 5,7-Dihydroxytryptamine; Analgesics, Non-Narcotic; Animals; Azetidines; Genes, Immediate-Early; Genetic Linkage; Immunohistochemistry; Male; Neurons; Nicotinic Agonists; Pain; Proto-Oncogene Proteins c-fos; Pyridines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Tryptophan Hydroxylase | 1998 |
ABT-594, a novel cholinergic channel modulator, is efficacious in nerve ligation and diabetic neuropathy models of neuropathic pain.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Azetidines; Cholinergic Antagonists; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Intraperitoneal; Ligation; Lumbosacral Region; Male; Morphine; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Nerves; Time Factors | 1998 |
Activation of spinal wide dynamic range neurons by intracutaneous microinjection of nicotine.
Topics: Action Potentials; Animals; Azetidines; Histamine; Histamine H1 Antagonists; Hot Temperature; Male; Mecamylamine; Microinjections; Narcotic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pain; Pyridines; Rats; Rats, Sprague-Dawley; Spinal Cord; Stimulation, Chemical; Tachyphylaxis | 1999 |
The identification of novel structural compound classes exhibiting high affinity for neuronal nicotinic acetylcholine receptors and analgesic efficacy in preclinical models of pain.
Topics: Analgesics; Animals; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Humans; Models, Molecular; Neurons; Nicotine; Nicotinic Agonists; Pain; Pyridines; Rats; Receptors, Nicotinic; Structure-Activity Relationship | 2000 |
Analgesic profile of the nicotinic acetylcholine receptor agonists, (+)-epibatidine and ABT-594 in models of persistent inflammatory and neuropathic pain.
Topics: Analgesics, Non-Narcotic; Animals; Arthritis, Experimental; Azetidines; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Freund's Adjuvant; Hyperalgesia; Inflammation; Male; Nicotinic Agonists; Pain; Pain Measurement; Postural Balance; Pyridines; Rats; Rats, Wistar; Receptors, Nicotinic; Sciatic Neuropathy | 2000 |